Recent Publications
Combined inhibition of JAK/STAT pathway and lysine-specific demethylase 1 as a therapeutic strategy in CSF3R/CEBPA mutant acute myeloid leukemia
Braun TP, Coblentz C, Smith BM, Coleman DJ, Schonrock Z, Carratt SA, Callahan RL, Maniaci B, Druker BJ, Maxson JE. PNAS. 2020.
Braun TP, Coblentz C, Smith BM, Coleman DJ, Schonrock Z, Carratt SA, Callahan RL, Maniaci B, Druker BJ, Maxson JE. PNAS. 2020.
Response and Resistance to BCR-ABL1 Targeted Therapies
Braun TP, Eide CA, Druker BJ. Cancer Cell. 2020
Braun TP, Eide CA, Druker BJ. Cancer Cell. 2020
Myeloid Lineage Enhancers Drive Oncogene Synergy in CEBPA/CSF3R Mutant Acute Myeloid Leukemia
Braun TP, Okhovat M, Coblentz C, Carratt SA, Foley A, Schonrock Z, Smith BM, Nevonen K, Davis B, Garcia B, LaTocha D, Weeder BR, Grzadkowski MR, Estabrook JC, Manning HG, Watanabe-Smith K, , Jeng S, Smith JL, Leonti AR, Ries RE, McWeeney S, Genua CD, Drissen R, Nerlov C, Meshinchi S, Carbone L, Druker BJ, Maxson JE. Nature Communications. 2019.
Braun TP, Okhovat M, Coblentz C, Carratt SA, Foley A, Schonrock Z, Smith BM, Nevonen K, Davis B, Garcia B, LaTocha D, Weeder BR, Grzadkowski MR, Estabrook JC, Manning HG, Watanabe-Smith K, , Jeng S, Smith JL, Leonti AR, Ries RE, McWeeney S, Genua CD, Drissen R, Nerlov C, Meshinchi S, Carbone L, Druker BJ, Maxson JE. Nature Communications. 2019.
Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome
Braun TP, Maxson JE, Agarwal A, Dunlap J, Spurgeon SE, Traer E. Leuk Res Rep. 2014.
Braun TP, Maxson JE, Agarwal A, Dunlap J, Spurgeon SE, Traer E. Leuk Res Rep. 2014.